Review and Testify on WSMA Resolutions by Sept. 11 Ahead of 2026 Annual Meeting
More than 60 resolutions and other items of business are now posted in the WSMA Virtual Reference Committee. All WSMA members are encouraged to review the resolutions and provide testimony.
The deadline for testimony in the virtual reference committee is noon on Friday, Sept. 11. Testimony submitted virtually after the Sept. 11 deadline will not be considered by the reference committees.
After Sept. 11, WSMA members who wish to testify on resolutions may do so in person at the 2026 WSMA Annual Meeting at the Historic Davenport in Spokane. The in-person reference committees will begin at 10 a.m. Saturday, Sept. 26.
Resolutions and other business now available for review and testimony
- Resolution B-1 B-22, A-25 (REFERRED) (B-20, A-24) Practice Requirements
- Resolution B-2 C-6 (REFERRED) Supporting a Washington Future Fund
- Resolution B-3 C-10 (REFERRED) Restricting Non-Medical Switching of Biologic Med
- Resolution B-4 C-22 (REFERRED) Halt the Use of Sewage Sludge (Biosolids)
- Resolution B-5 Bylaws Report C (REFERRED)
- Resolution B-6 Bylaws Report D (REFERRED)
- Resolution B-7 WSMA Policy Sunset Review
- Resolution B-8 Federal Oversight, Transparency, and Contractor Accountability in Medicare Prior Authorization
- Resolution B-9 Fair Recoupment Standards for L&I Physicians
- Resolution B-10 Modernizing Product Liability for Clinical Artificial Intelligence Failures
- Resolution B-11 Biosimilar Cost Transparency
- Resolution B-12 Increased Inclusion of Immunocompromised Patients in Clinical Trial
- Resolution B-13 Facilitating Clinical Shadowing Opportunities for Washington Pre-Medical Students
- Resolution B-14 Provision of Toolkits for Physicians and Patients Regarding Law Enforcement Engagement
- Resolution B-15 Repeal Resolutions Separate from Reports (A-18)
- Resolution B-16 Opposition to the Use of Political Appointees for Final Decisions on Federally Funded Research Grants
- Resolution B-17 Standardizing Inpatient Stabilization, Rapid MOUD Initiation, and Appropriate High-risk Reimbursement for Pregnant Patients with Fentanyl and Opioid Use Disorder
- Resolution B-18 Revising Washington Pain Rules into Recommendations
- Resolution B-19 Differentiated Pathways, Referral Standards, and Structural Reform for the Washington Physicians Health Program
- Resolution B-20 Continuity of Care for Established Patients Traveling Out of State
- Resolution B-21 Ensuring Adequate Diagnostic Evaluation Before Prescribing Controlled Substances
- Resolution B-22 Evidence Based Care for Those Incarcerated or Confined with Serious Mental Illness or Substance Use Disorder
- Resolution B-23 Ensuring Appropriate Clinical Evaluation and Follow-Up for Direct-to-Consumer Prescription Medication Services for Erectile Dysfunction
- Resolution B-24 Ensuring Appropriate Clinical Evaluation and Follow-Up for Direct-to-Consumer Prescription Testosterone Replacement Therapy Medication Services
- Resolution B-25 Non-Compete Clauses Related to Health Professional Shortage Areas
- Resolution B-26 Prohibiting Geographic Restrictions on Specialty and Subspecialty Care
- Resolution B-27 Reimbursement for Prior Authorization Activities
- Resolution B-28 Rural Network Adequacy in Medicare Advantage
- Resolution C-1 Psilocybin Safety Policy
- Resolution C-2 Sustainability and Retention for Child Abuse Medical Teams
- Resolution C-3 Prohibiting and Regulating 7-Hydroxymitragynine (Kratom) Products
- Resolution C-4 WSMA to Publicly Oppose Initiative 645 to Repeal Tax on High Income (“Millionaire’s Tax)
- Resolution C-5 Support Baby Bonds in Washington State
- Resolution C-6 Addressing the Health Impacts of Excessive Educational Technology (EdTech) Use in Washington Schools
- Resolution C-7 Washington Apple Health Prior Authorization Safeguards and Transparency Standards
- Resolution C-8 State Oversight of Artificial Intelligence in Health Insurance Medical Necessity Decisions
- Resolution C-9 Limit Aviation Fuel Health Harms
- Resolution C-10 Commonsense Limits on Medical Debt Interest to Protect Both Patients and Clinicians
- Resolution C-11 Restricting Cell Phone Use During Instructional Hours in Washington Schools
- Resolution C-12 Patient Disclosure of Clinician Credentials and Informed Consent
- Resolution C-13 Kratom and Kratom-Derived Products
- Resolution C-14 Establishing Clinical Screening, Counseling, and Supervised Care Standards for Prenatal Kratom Exposure and Neonatal Abstinence Risk
- Resolution C-15 Strengthening Washington’s Prior Authorization Law
- Resolution C-16 Universal Primary Care
- Resolution C-17 Over the Counter Use of Tianeptine
- Resolution C-18 Expanding Behavioral Health Access Through Primary Care Physician Training
- Resolution C-19 Supporting Family Physicians in the Provision of Prenatal and Obstetric Care
- Resolution C-20 Use of Over-the-Counter Male Sexual Enhancement Supplements Containing PDE5 inhibitors and/or Sibutramine
- Resolution C-21 Improved Medicare for All
- Resolution C-22 Protecting Adolescent Access to Gender-Affirming Care from Federal Preemption and Funding Restrictions
- Resolution C-23 Psilocybin-Assisted Psychotherapy
- Resolution C-24 Prioritizing Child Safety in Custody Decisions
- Resolution C-25 Title Transparency in the Telemedicine Setting
- Resolution C-26 Protecting the Title “Physician” and “Physician Assistant” from Artificial Intelligence Misrepresentation and Impersonation
- Resolution C-27 Bicyclist-Safety Training for Bus Drivers
- Resolution C-28 Out-of-Network PCP Referral and Care Coordination Protections
- Resolution C-29 Universal Pediatric Care
- Resolution C-30 Patient Access to Medical Care in Ferry-Served Communities
- Resolution C-31 Imposing a Statewide Excise Tax of At Least Two Cents per Ounce on the Distribution of Sweetened Beverages
- Resolution C-32 Supporting Policies that Promote a Play-Based Childhood for Thriving Children
- Resolution C-33 Ensuring Appropriate Clinical Evaluation and Follow-Up for General Direct-to-Consumer Prescription Medication Services
- Resolution C-34 Ensuring Appropriate Clinical Evaluation and Follow-Up for Direct-to-Consumer Prescription Medication Services for Weight Loss and Off-label Medications
- Resolution C-35 Full Repeal of the Certificate of Need Program
- HOD Bylaws Report A
- HOD Bylaws Report B-Amendment-Article XIV Recall Referendum Initiative
- HOD Bylaws Report C-Amendment-Article V-VI 1
- HOD Bylaws Report D-Amendment Information Report (B-13)
About the virtual reference committee
The virtual reference committee is a password-protected online discussion forum that gives all WSMA members an opportunity to participate in the policymaking process. If you have not yet joined the virtual reference committee, visit the WSMA website for step-by-step instructions. If you already have an account, go directly to the virtual reference committee.
Beginning in 2026, testimony submitted through the virtual reference committee by the Sept. 11 deadline will be used to draft preliminary reference committee reports in advance of the WSMA Annual Meeting:
- The preliminary reports will be posted to the WSMA website, virtual reference committee, and distributed via email to delegates by Sept. 18. This will allow for a week for delegations to caucus.
- The reports will be presented as consent calendars during the in-person reference committee sessions Saturday, Sept. 26, during the Annual Meeting.
- Delegates may extract items from the consent calendar during the opening session of the House of Delegates on Saturday morning and during the subsequent in-person reference committee for discussion, debate, and amendment during the reference committee meetings.
After the in-person reference committee meetings, the preliminary reference committee reports will be revised and considered by the full House on Sunday, with the same opportunities for extraction and deliberation.
These new processes are designed to improve efficiency, accessibility, and delegate engagement. Learn more about these changes in this five-minute video. For an in-depth look at how physician ideas become WSMA policy, review this video made by Speaker of the House Matthew Grierson, MD.
Testimony provided through the virtual reference committee is given equal weight to in-person testimony.
How to testify in the virtual reference committee
Use the following format when submitting online testimony:
- Introduce yourself: State your name and delegation (or other role, if applicable).
- State whom you represent: Indicate whether you are speaking on your own behalf or on behalf of your delegation.
- Clearly state your position: Begin your testimony with one of the following: “I support this resolution,” “I oppose this resolution,” or “I support this resolution with amendment(s).”
- Explain your reasoning: Briefly describe the rationale for your position. If proposing amendments, be as specific as possible and include suggested wording whenever feasible.
Following this format and keeping testimony concise will help the reference committees efficiently review and consider all comments.
Thank you for reviewing the resolutions and providing your expertise and perspective by the noon Sept. 11 deadline.
More information on policymaking at the House of Delegates:
Reference Committee Hearings & Reports – An in-depth overview of the role of the virtual reference committee, reference committee members, the new preliminary reference committee reports, and the in-person reference committee hearings in shaping policy at the WSMA. Includes the rules that govern the in-person committee hearings.
House of Delegates Orientation – An overview of the WSMA House of Delegates, why it exists, the roles and responsibilities of individual delegates, and how the decision-making process at the House of Delegates works. Includes the general rules of order during the House sessions, and information about the structure of resolutions and how they’re debated.